Episode 44 - Uwe Schoenbeck, Partner of Canaan

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.

On this episode of The BioHub, I’m joined by Uwe Schoenbeck, Partner at Canaan and one of the most respected names in early-stage biotech.

After more than a decade leading external science and innovation at Pfizer, Uwe made the jump to venture capital, joining Canaan in 2023. With a background spanning big pharma, startups, and science itself—he’s uniquely positioned to see what’s coming next.

In this episode, we talk about the shift from pharma to VC, what founders get wrong when pitching, and the traits that separate the good companies from the great ones.

Enjoy and stay tuned.